TickerFactsScreenerDevelopers

BioRestorative Therapies, Inc. (BRTX) — Revenue

Annual figures by fiscal year, from SEC filings.

2017: $81.0K2018: $111.0K2019: $130.0K2020: $77.0K2021: $46.0K2022: $119.8K2023: $145.8K2024: $401.0K2025: $359.7K$359.7K
2017Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$359.7K-10.3%
2024$401.0K+175.0%
2023$145.8K+21.7%
2022$119.8K+160.4%
2021$46.0K-40.3%
2020$77.0K-40.8%
2019$130.0K+17.1%
2018$111.0K+37.0%
2017$81.0K—